全 民 健 康 保 險 年 報
National Health Insurance In Taiwan
2013-2014
ANNUAL REPORT
健保署為了掌握市場上藥品的實際交
易價格，自
1999
年起，依據調查的結果，
將醫療院所壓低的藥價，反映至調降藥品的
支付價格，至今共辦理
7
次藥價調整，目
前已累計調降約
300
多億元的藥費。歷次
藥價調降，除了縮小藥價差距，亦減緩藥
費支出成長，每次藥價調降所節省的費用，
用於加速新藥收載及給付、調整支付標準
偏低之項目，以提供國內民眾享有與世界
先進國家同步的醫療用藥，同時也提升了
醫療品質，對於全民的健康保障，具有實
質的效益。
The process of surveying market prices for drugs and
adjusting reimbursed amounts according to the surveyed
prices began in 1999, and seven rounds of adjustments have
been made since then, saving the NHI system more than
NT$30 billion over that time. These periodic adjustments
have helped narrow the gap between actual market prices and
NHI-listed prices and slowed the growth of the system’s drug
expenditures. The money saved through the process has been
used to extend coverage to new drugs and increase listed drug
prices that were found to be too low, ensuring that patients
have access to drugs in step with developed countries around
the world and that the quality of care improves.